Literature DB >> 30388212

Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing Therapy.

Ani Kardashian1, Jeff McKinney2, Nina Huynh3, Robin Yu4, Marion Peters5, Lisa Catalli2, Jennifer C Price5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30388212      PMCID： PMC6495007          DOI： 10.1093/cid/ciy951

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

Review 1.  Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis.

Authors:  Siddharth Singh; Antonio Facciorusso; Rohit Loomba; Yngve T Falck-Ytter
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05-04       Impact factor: 11.382

Review 2.  American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.

Authors:  Siddharth Singh; Andrew J Muir; Douglas T Dieterich; Yngve T Falck-Ytter
Journal:  Gastroenterology       Date:  2017-05       Impact factor: 22.682

3.  A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.

Authors:  Soo Aleman; Nogol Rahbin; Ola Weiland; Loa Davidsdottir; Magnus Hedenstierna; Nina Rose; Hans Verbaan; Per Stål; Tony Carlsson; Hans Norrgren; Anders Ekbom; Fredrik Granath; Rolf Hultcrantz
Journal:  Clin Infect Dis       Date:  2013-04-24       Impact factor: 9.079

4.  The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.

Authors:  Roberta D'Ambrosio; Alessio Aghemo; Mirella Fraquelli; Maria Grazia Rumi; Maria Francesca Donato; Valerie Paradis; Pierre Bedossa; Massimo Colombo
Journal:  J Hepatol       Date:  2013-03-23       Impact factor: 25.083

5.  Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy.

Authors:  V Knop; D Hoppe; T Welzel; J Vermehren; E Herrmann; A Vermehren; M Friedrich-Rust; C Sarrazin; S Zeuzem; M-W Welker
Journal:  J Viral Hepat       Date:  2016-08-08       Impact factor: 3.728

6.  Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.

Authors:  Hashem B El-Serag; Fasiha Kanwal; Peter Richardson; Jennifer Kramer
Journal:  Hepatology       Date:  2016-04-19       Impact factor: 17.425

7.  Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus-infected patients with a sustained virological response.

Authors:  Y Tachi; T Hirai; Y Kojima; A Miyata; K Ohara; Y Ishizu; T Honda; T Kuzuya; K Hayashi; M Ishigami; H Goto
Journal:  Aliment Pharmacol Ther       Date:  2016-06-13       Impact factor: 8.171

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
  8 in total
  1 in total

1.  What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?

Authors:  Jin Wook Kim
Journal:  J Korean Med Sci       Date:  2019-10-28       Impact factor: 2.153
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.